E
Cytek Biosciences, Inc. CTKB
$4.14 -$0.03-0.72% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -5.58M -11.40M 9.64M 940.00K -10.43M
Total Depreciation and Amortization 2.99M 2.88M 2.74M 2.81M 2.48M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 3.49M 5.36M -4.89M 6.21M 6.05M
Change in Net Operating Assets -785.00K 3.03M -5.50M 3.26M 8.11M
Cash from Operations 108.00K -125.00K 2.00M 13.22M 6.20M
Capital Expenditure -1.58M -849.00K -894.00K -1.01M -1.05M
Sale of Property, Plant, and Equipment 23.00K 33.00K 191.00K 21.00K 76.00K
Cash Acquisitions -- -- -471.00K -- --
Divestitures -- -- -- -- --
Other Investing Activities -14.86M 10.27M -62.26M -14.82M 3.00M
Cash from Investing -16.41M 9.45M -63.43M -15.81M 2.02M
Total Debt Issued 1.39M 690.00K 2.79M 5.00K -3.00K
Total Debt Repaid -142.00K -1.52M -139.00K -140.00K -139.00K
Issuance of Common Stock 767.00K 39.00K 835.00K 147.00K 1.23M
Repurchase of Common Stock -4.61M -10.76M -7.12M -12.10M -2.80M
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -2.60M -11.55M -3.64M -12.08M -1.71M
Foreign Exchange rate Adjustments -921.00K -1.23M 1.52M -943.00K 2.26M
Miscellaneous Cash Flow Adjustments -1.00K -- -- -- --
Net Change in Cash -19.83M -3.45M -63.56M -15.62M 8.78M